靶向SOX9调控弥漫性大B细胞淋巴瘤代谢重编程的研究

张漪蓉, 魏玮庆, 马皎, 张雪

Research on the role of SOX9 in regulating metabolic reprogramming in diffuse large B cell lymphoma

ZHANG Yirong, WEI Weiqing, MA Jiao, ZHANG Xue

图2 SOX9 表达对ABC亚型的DLBCL患者生存的影响 Note： A. Kaplan-Meier survival curve comparing the overall survival time for different SOX9 expression groups (upper 50% vs lower 50%) in GCB-DLBCL from NCICCR-DLBCL patient cohort. B. Distribution of IPI scores between different SOX9 groups (upper 50% vs lower 50%) in GCB-DLBCL from the NCICCR-DLBCL patient cohort. C. Kaplan-Meier survival curve comparing the overall survival time for different SOX9 expression groups (upper 50% vs lower 50%) in ABC-DLBCL from NCICCR-DLBCL patient cohort. D. Distribution of IPI scores between different SOX9 groups (upper 50% vs lower 50%) in ABC-DLBCL from the NCICCR-DLBCL patient cohort. "Low risk" contains "Low risk" and "Low-intermediate risk" in original cohort, likewise the "High". Statistical significance was determined by Fisher's exact test.

Fig 2 SOX9's effect on DLBCL patients' survival